ANRO peer analysis
Alto Neuroscience (ANRO) against its competitors: price, today's move, 1-year return and market value side by side.
ANRO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACIU AC Immune | $2.11 | -7.86% | -38.48% | $214.74M |
| ALDX Aldeyra Therapeutics | $0.62 | -4.87% | -87.51% | $37.16M |
| AMRN Amarin | $11.57 | -5.51% | -24.40% | $244.50M |
| CLLS Cellectis | $1.03 | -11.97% | -68.40% | $74.26M |
| CTNM Contineum Therapeutics | $9.52 | 8.06% | -9.00% | – |
| DBVT DBV Technologies | $10.45 | 6.63% | -25.71% | $658.64M |
| DRTS Alpha Tau Medical | $14.01 | 5.31% | 246.72% | – |
| KRRO Korro Bio | $14.75 | 0.14% | -53.26% | – |
| LRMR Larimar Therapeutics | $2.30 | -0.86% | -25.93% | $247.76M |
| SLN Silence Therapeutics | $19.78 | 0.33% | 216.11% | – |
| ANRO Alto Neuroscience | $25.03 | 14.45% | 122.85% | – |
- ANRO's peers: ACIU (AC Immune), ALDX (Aldeyra Therapeutics), AMRN (Amarin), CLLS (Cellectis), CTNM (Contineum Therapeutics), DBVT (DBV Technologies), DRTS (Alpha Tau Medical), KRRO (Korro Bio).
Updated 2026-11-07 11:54 UTC